Articles related to Hematology

Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond

“The idea of preserving and reducing thrombosis without increasing bleeding is very, very exciting.” — Roxana Mehran, MD, SCAI 2025

Cardiology March 25th 2026

Tags: ACUTE CORONARY SYNDROME (ACS) ANTICOAGULATION MANAGEMENT ANTITHROMBOTIC THERAPY BLEEDING/BLOOD DISORDERS CME DUAL ANTIPLATELET THERAPY (DAPT) FACTOR XI INHIBITION

Hematology Advisor

Long-Distance Endurance Running May Impact Red Blood Cell Aging

“Extreme endurance exercise pushes red blood cells toward accelerated aging through mechanisms that mirror what we observe during blood storage.” — Angelo D’Alessandro, PhD, University of Colorado Anschutz

Cardiology March 17th 2026

Tags: ANEMIA BLOOD CELL BIOLOGY EXERCISE/TRAINING SPORTS MEDICINE TRANSFUSION MEDICINE

News Medical

New Guidelines Outline Comprehensive Care for Acute Pulmonary Embolism

“This guideline is a road map to help clinicians navigate these advances for the safest and most effective approaches to care.” — Mark A. Creager, MD, Dartmouth Health

Emergency Medicine March 16th 2026

Tags: ANTICOAGULATION MANAGEMENT CARDIOVASCULAR RISK GUIDELINES/RECOMMENDATIONS PULMONARY EMBOLISM VENOUS THROMBOEMBOLISM (VTE)

Annals of Internal Medicine

The Risk for Bleeding in Patients with Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban with Diltiazem Compared with Metoprolol

The primary study outcome was a composite of serious bleeding events leading to hospitalization. Secondary study outcomes included composites of stroke or systemic embolism.

Cardiology March 10th 2026

Tags: ANTICOAGULATION MANAGEMENT ATRIAL FIBRILLATION (AFIB) BLEEDING/BLOOD DISORDERS DRUG SAFETY & INTERACTIONS

Hematology Advisor

CHIP Significantly Associated with Heart Failure

“CHIP, especially non-DNMT3A CHIP, was independently associated with incident HF. Future research should explore the gene-specific mechanisms by which CHIP variants promote HF in humans.” — Study Authors, JAMA Cardiology

Cardiology March 3rd 2026

Tags: CARDIOVASCULAR RISK CLONAL HEMATOPOIESIS (CH) ELECTROPHYSIOLOGY GENOMICS HEART FAILURE (HF)

Hematology Advisor

IV Iron Dextran Results in Higher QALYs vs Oral Iron

First-line treatment with IV iron dextran is the cost-effective strategy for managing IDA in women with HMB at commonly accepted willingness-to-pay thresholds.

Hematology February 2nd 2026

Tags: ANEMIA BLEEDING/BLOOD DISORDERS HEALTHCARE COSTS MENSTRUAL CYCLE WOMEN'S HEALTH

1 2 … 64 65 >>

Trending Topics:

Articles related to Hematology

View More Articles On:

Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond

Long-Distance Endurance Running May Impact Red Blood Cell Aging

New Guidelines Outline Comprehensive Care for Acute Pulmonary Embolism

The Risk for Bleeding in Patients with Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban with Diltiazem Compared with Metoprolol

CHIP Significantly Associated with Heart Failure

IV Iron Dextran Results in Higher QALYs vs Oral Iron

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form